Stephen Porada

Stephen Porada has held various roles in different companies throughout their career. In 1997, they worked at Cytyc in multiple positions. From 2010 to 2015, they were a partner at Aventine Co. Starting in 2015, they joined PAINWeek as the VP of Corporate and Business Development, where they managed and developed client brand marketing. In 2018, they became a shareholder at Verséa Holdings, Inc., a company specializing in pharmaceutical-grade hemp-derived cannabidiol products. In 2019, they co-founded Verséa Holdings, Inc. and assumed the role of Chief Operating Officer. Additionally, they became a shareholder at iFoods. Throughout their career, Porada has been involved in various areas such as communications, project development, marketing strategies, and Risk Evaluation and Mitigation Strategy solution development.

Stephen Porada attended Mount St. Mary's University from 1983 to 1987, where they earned a Bachelor of Science (BS) degree in Biology, General. There is no available information about their education after graduating from Mount St. Mary's University. However, it is known that they did not attend Monmouth University as there are no records of him obtaining a degree or pursuing any field of study there.